This product line is essential in the development of an effective parasite control program for horses and has been formulated to guarantee animal safety.
Flavored oral gel
Equix® is a broad spectrum antiparasitic composed by two drugs with different activities to cover the vast majority of parasite infestation in horses.
Moxidectin belongs to the group of milbemycins, effective for the treatment of most equine parasitosis caused by nematodes and arthropods.
To complete the spectrum of activity, praziquantel -a pyrazinoquinolone- has specific activity against equine cestodes.
Moxidectin has proved to be 100% effective against Strongylus vulgaris in their adult stage, S. edentatus, Triodontophorus spp., and 22 species of strongyles in horse’s small intestine. It has also proved to be 100% effective against S. edentatus and Oxyuris equi in their larvae stage, and 94% effective against the adult stage of the latter and the larvae stage of S. vulgaris.
Nematodes: Strongylus vulgaris, Strongylus edentatus and Strongylus equinus, Triodontophorus spp., Cyathostomum spp., Trichostrongylus axei, Parascaris equorum, Oxyuris equi, Strongyloides westeri, Habronema muscae, Draschia megastoma and larvae stages of Onchocerca spp.
Its high antiparasitic effectiveness is not only achieved during the intestinal stage of parasites, but also during the larval migration stages of the Strongylidea, Ascaridoidea and Rhabditoidea families.
Moxidectin reduces Strongylus egg count 12-16 weeks after treatment.
Arthropods: Gasterophilus intestinalis, Gasterophilus nasalis and Gasterophilus hemorrhoidalis.
For the treatment of arthropods, effectiveness achieved was 96% against Gasterophilus intestinalis at a dose of 0.4-0.5 mg/kg, also showing activity against larvae stages of the parasite while in horse’s stomach or intestine walls.
Praziquantel is effective against the tree species of cestodes that affect horses: Anoplocephala perfoliata, Anoplocephala magna and Paranoplocephala mamillana.
Content One 12.34 g prefilled syringe.
- Moxidectin 1.95 g.
- Preziquantel 12.17 g.
- Excipients q. s. 100,00 g.
RAZIX® is a broad spectrum antiparasitic indicated for the treatment of gastrointestinal and pulmonary Nematodes, Cestodes, and cutaneous parasites in equids.
Susceptible etiologic agents:
Large strongyles: Strongylus edentatus (adults and encysted larvae), Strongylus equinus (adults), Strongylus vulgaris (adults and arterial larvae), Triodontophorus spp. (adults). Small strongyles: Cyathostominae (adults and larvae L3 and L4), Cyathostomum spp., Cylicodontophorus spp., Cylicocyclus spp., Cylicostephanus spp., Gyalocephalus spp., Poteriostomum spp.
Other nematodes: Oxyuris equi (adults and larvae L3 and L4), Parascaris equorum (adults L3 and L4), Trichostrongylus axei (adults), Strongyloides westeri (adults). Pulmonary parasites: Dictyocaulus arnfieldi (adults and immature).
Cutaneous nematodes: Draschia spp. (larval stages, “summer sores”), Habronema majus (larval stages, “summer sores”), Habronema majus (larval stages, “summer sores”). Microfilariae: Onchocerca spp. and O. cervicalis.
Cestodes: Anoplocephala magna, Anoplocephala perfoliata, Paranoplocephala mamillana (adults and immature forms, scolex and body).
Larvae: Dictyocaulus arnfieldi (adults and larvae L4).
Gasterophilus intestinalis (L2 and L3, “horse bot fly”), Gasterophilus nasalis (L2 and L3, “rennet worm”).
Content: One 10 g prefilled syringe. One 30 g prefilled syringe.
- Ivermectin 12,00 mg
- Praziquantel 150,00 mg
- Excipients q. s. 1.000 mg